|
Quick Start Approach to Birth Control Pills Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on Quick Start Approach to Birth Control Pills conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Quick Start Approach to Birth Control Pills Clinical research trials and Quick Start Approach to Birth Control Pills medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like Quick Start Approach to Birth Control Pills. Quick Start Approach to Birth Control Pills Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a Quick Start Approach to Birth Control Pills clinical trial. Subjects typically recieve the finest healthcare available for their Quick Start Approach to Birth Control Pills condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "Q" Clinical Trials Conditions > Quick Start Approach to Birth Control Pills  Quick Start Approach to Birth Control Pills
Quick Start Approach to Birth Control Pills
For Condition: Contraception,Pregnancy
Status: Recruiting
Sponsor(s): National Institute of Child Health and Human Development (NICHD) ,
Synopsis: Women who choose to take birth control pills are currently instructed to begin taking the pills at the end of a menstrual cycle. This creates a window of time between when the woman is given the pills and when she begins taking them. Some women fail to begin taking the pills, placing them at increased risk of pregnancy. This study will evaluate a new approach to beginning birth control pills. Women will take the first pill in the doctor’s office rather than waiting until the next menstrual cycle.
Details: Despite the effectiveness of oral contraceptives, pregnancy rates are high among women who choose this method of birth control. These pregnancies occur due to incorrect use, premature discontinuation, and failure to begin taking oral contraceptives after they have been prescribed. As many as 25% of adolescents who seek oral contraceptives from family planning clinics never take the first pill. Failure to begin oral contraceptives may occur due to ambivalence, confusion about starting instructions, or intervening pregnancy. Conventional starting instructions for oral contraceptives require waiting until the next menstrual period; this may leave the woman at high risk of pregnancy. This trial will evaluate a "quick start" approach in which the woman swallows the first pill during the clinic visit under direct observation and then continues daily pill use without waiting for her next menses. The trial will determine whether immediate oral contraceptive initiation offers benefits compared to conventional starting approaches. Participants in this study will be randomized to receive either the quick start or the standard starting approach. Participants will complete a questionnaire at study entry and Months 3 and 6. The main outcomes are 6-month oral contraceptive continuation rates and pregnancy rates.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study
Minimum Age/Maximum Age: /24 Years
Genders: Female
Protocol Entry Criteria: Inclusion Criteria - Requests hormonal contraceptives as primary method of contraception - Sexually active (intercourse within 30 days prior to study entry) or anticipating sexual activity within 30 days following study entry
Total Enrollment: 2000
Location and Contact Information:
Overall Study Official:
CarolynWesthoff, Principal Investigator, Columbia University
Mt. Sinai School of Medicine *Recruiting*
New York City, New York, 10128
United States
Recruiting
Emory University School of Medicine *Recruiting*
Atlanta, Georgia, 30303
United States
Recruiting
University of Texas Southwestern Medical Center at Dallas *Recruiting*
Dallas, Texas, 75235
United States
Recruiting
Additional Information:
Study ID Numbers: HD42413;
Study Start Date: February 2003
Record last reviewed: September 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00068848
Other Pregnancy Studies:
1. A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women
2. Ultrasound and motivational enhancement for prenatal smoking cessation
3. Effectiveness of BufferGel as a Vaginal Contraceptive
4. Setting up a Blood Bank for Gene Therapy in HIV-Infected Infants
5. Vulnerability of the Fetus/Infant to PAH, PM2.5 AND ETS.
Related Studies:
Other Pregnancy Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
Quick Start Approach to Birth Control Pills
|
|
|
|
|
|
|
|
